Matches in Nanopublications for { ?s ?p "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP357394.RAD1WHPBsbzKYQ9UyExuZd73wNYq-wZq2OfZJiC0is-wk130_assertion description "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357394.RAD1WHPBsbzKYQ9UyExuZd73wNYq-wZq2OfZJiC0is-wk130_provenance.
- NP350178.RALv1cGCB1PuftazHCkq6NDw--F21hR1G0lTGAlnWIl9Y130_assertion description "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350178.RALv1cGCB1PuftazHCkq6NDw--F21hR1G0lTGAlnWIl9Y130_provenance.
- NP631005.RAdM5Z8vybpppk1De4ihSAFmOYyoB8rnBLo7Ji7EWsdlI130_assertion description "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP631005.RAdM5Z8vybpppk1De4ihSAFmOYyoB8rnBLo7Ji7EWsdlI130_provenance.
- assertion description "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP938489.RA2x2wbMPPXPodtcnm2hMny1pKA2cbGK034BqMxVbCT4Q130_assertion description "[Indeed, allosteric or genetic inhibition of phospho-Ser338 CRAF impairs Plk1 activation and accumulation at the kinetochores, causing prometaphase arrest, whereas a phospho-mimetic Ser338D CRAF mutant potentiates Plk1 activation, mitosis and tumor progression in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938489.RA2x2wbMPPXPodtcnm2hMny1pKA2cbGK034BqMxVbCT4Q130_provenance.